Cite
HARVARD Citation
Bhattarai, M. et al. (2021). Comprehensive evaluation of cardiovascular efficacy and safety outcomes of SGLT2 inhibitors in high risk patients of cardiovascular disease: systematic review and meta-analysis. Cardiovascular endocrinology & metabolism. 10 (2), pp. 89-98. [Online].